Abstract
We review the current status and future directions of sestamibi single‐photon emission‐computed tomography (SPECT), positron emission tomography (PET), magnetic resonance imaging (MRI), and contrast perfusion echocardiography (CPE) for coronary artery disease evaluation. Diagnostic accuracy and adjunctive assessment of ventricular function make sestamibi SPECT the currently favored stress imaging radioisotope technique. Tissue attenuation correction will likely enhance these capabilities of SPECT in the near future. PET potentially offers valuable diagnostic information, as it may be a superior technique where body habitus limits cardiac imaging. We project that it is unlikely to become routinely used for cardiac imaging because of improvements in routine radionuclide imaging and the lack of evidence that the small resolution gain with PET is of importance, given the much larger cost. Cardiac MRI for assessing cardiac function, perfusion, and coronary angiography is an exciting new modality at an early stage of development. The possible comprehensive nature of MRI for coronary artery disease evaluation, potential cost savings related to utilization of a single, noninvasive test, and availability of scanning equipment in current community settings all project an important role for MRI in the future. Contrast perfusion echocardiography is also a relatively new and untested imaging modality which offers great future promise. The recent development of intravenous contrast agents and the current widespread availability of echocardiographic expertise and equipment throughout the country suggest that the speed of development as well as the dispersion of technologic advances will be rapid. We project that these techniques will play important roles in future coronary artery disease testing and will result in improved diagnostic efficacy and possibly cost utility.
Keywords: coronary artery disease, imaging, diagnosis
Full Text
The Full Text of this article is available as a PDF (1.3 MB).
References
- 1. Ladenheim ML, Pollack BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA: Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986; 7: 464–471 [DOI] [PubMed] [Google Scholar]
- 2. Lee KL, Pryor DB, Pieper KS, Harrell FE Jr, Califf RM, Mark DB, Hlatky MA, Coleman RE, Cobb FR, Jones RH: Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation 1990; 82: 1705–1717 [DOI] [PubMed] [Google Scholar]
- 3. Van Train KF, Berman DS, Garcia E, Berger HJ, Sands MJ, Friedman JD, Freeman MR: Quantitative analysis of stress Tl‐201 myocardial scintigrams: A multicenter trial validation utilizing standard normal limits. J Nucl Med 1986; 21: 17–25 [PubMed] [Google Scholar]
- 4. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A: Stress echocardiography and the human factor: The importance of being expert. J Am Coll Cardiol 1991; 17: 666–669 [DOI] [PubMed] [Google Scholar]
- 5. Kiat H, Maddahi J, Roy L, Friedman J, Berman DS: Comparison of Tc‐99m methoxy isobutyl isonitrile with Tl‐201 imaging by planar and SPECT techniques for assessment of coronary disease. Am Heart J 1989; 17 (1):1–11 [DOI] [PubMed] [Google Scholar]
- 6. Wackers F, Berman D, Maddahi J, Watson D, Beller G, Strauss HW, Boucher C, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof‐Delaloye A, Camin L, McKusick K: Technetium‐99m hexakis 2‐methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium‐201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301–311 [PubMed] [Google Scholar]
- 7. Rozanski A, Diamond GA, Berman DS, Forrester JS, Morris D, Swan HJC: The declining specificity of exercise radionuclide ventriculography. N Engl J Med 1983; 309: 518–522 [DOI] [PubMed] [Google Scholar]
- 8. Van Train KF, Maddahi J, Berman DS, Kiat H, Areeda J, Pringent F, Friedman J: Quantitative analysis of tomographic stress thallium‐201 myocardial scintigrams: A multicenter trial. J Nucl Med 1990; 31: 1168–1179 [PubMed] [Google Scholar]
- 9. Berman DS, Kiat H, Wang FP, Van Train K, Germano G, Matzer L, Maddahi J, Friedman JD: Separate acquisition rest thallium‐201/stress technetium‐99m sestamibi dual isotope myocardial perfusion SPECT: A clinical validation study. J Am Coll Cardiol 1993; 22: 1455–1464 [DOI] [PubMed] [Google Scholar]
- 10. Kiat H, Areeda J, Van Train K, Silagan G, Wang FP, Germano G, Gonzalez J, Friedman J, Berman DS: Quantitative assessment of stress defect extent and reversibility on rest Tl‐201/stress Tc‐99m sestamibi dual isotope myocardial perfusion SPECT: A prospective validation. Circulation 1993; 88 (4):I‐440 [Google Scholar]
- 11. Garcia EV, Cooke D, Van Train KF, Folks R, Peifer J, DePuey G, Maddahi J, Alazraki N, Galt J, Ezquerra N, Ziffer J, Areeda J, Berman DS: Technical aspects of myocardial SPECT imaging with technetium‐99m sestamibi. Am J Cardiol 1990; 66: 23E–31E [DOI] [PubMed] [Google Scholar]
- 12. Van Train K, Areeda J, Garcia E, Cooke D, Maddahi J, Kiat H, Germano G, Silagan G, Folks R, Berman D: Quantitative same day rest stress technetium‐99m sestamibi SPECT: Definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993; 34: 1494–1502 [PubMed] [Google Scholar]
- 13. Germano G, Kavanagh PB, Kiat H, Chua T, Berman DS: Automatic analysis of gated myocardial SPECT: Development and initial validation of a method. J Nucl Med 1994; 35: 116P [Google Scholar]
- 14. Mazzanti M, Germano G, Kiat H, Kavanagh P, Alexanderson B, Boaz B, Friedman J, Cabico A, Berman DS: Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation in dual isotope myocardial perfusion SPECT. Circulation 1994; 90: I‐445 [DOI] [PubMed] [Google Scholar]
- 15. Chua T, Kiat H, Maurer G, Germano G, Van Train K, Friedman J, Berman DS: Gated technetium‐99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: Correlation with echocardiography and rest thallium‐201 scintigraphy. J Am Coll Cardiol 1994; 23: 1104–1111 [DOI] [PubMed] [Google Scholar]
- 16. Hachamovitch R, Benari B, Kiat H, Friedman J, Germano G, Van Train K, Diamond GA, Berman DS: Exercise first pass ejection fraction adds additional prognostic information in patients with abnormal Tc‐99m myocardial perfusion SPECT. Circulation 1994; 90: I‐448 [Google Scholar]
- 17. Okada RD, Glover D, Gaffney T, Williams S: Myocardial kinetics of technetium‐99m‐hexakis‐2‐methoxy‐2‐methylpropyl‐isonitrile. Circulation 1988; 77: 491–498 [DOI] [PubMed] [Google Scholar]
- 18. Hachamovitch R, Berman DS, Kiat H, Bairey Merz CN, Cohen I, Cabico JA, Friedman J, Germano G, Van Train KF, Diamond GA: Gender‐related differences in clinical management after exercise nuclear testing. J Am Coll Cardiol 1995; 26: 1457–1464 [DOI] [PubMed] [Google Scholar]
- 19. ACC/AHA Task Force Report : Guidelines for Clinical Use of Cardiac Radionuclide Imaging. J Am Coll Cardiol 1995; 25: 521–547 [DOI] [PubMed] [Google Scholar]
- 20. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Smailing RW: Diagnosis of coronary artery disease by positron imaging: Large scale clinical trial. J Am Coll Cardiol 1988; 9E–11E
- 21. Berman DS, Kiat H, Van Train KF, Friedman J, Garcia EV, Maddahi J: Comparison of SPECT using technetium‐99m agents and thallium‐201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990; 66: 72E–79E [DOI] [PubMed] [Google Scholar]
- 22. Stewart RE, Schwaiger M, Molina E, Popma J, Gachioch GM, Kalies M, Squicciarini S, al‐Aouar ZR, Schork A, Kuhl DR: Comparison of rubidium‐82 positron emission tomography and thallium‐210 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991; 67: 1303–1310 [DOI] [PubMed] [Google Scholar]
- 23. Go RT, Marwick TH, MacIntyre WJ, Saba GB, Neumann DR, Underwood DA, Simpfendorfer CC: A prospective comparison of rubidium‐82 PET and thallium‐201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990; 31: 1899–1905 [PubMed] [Google Scholar]
- 24. Bonow RO, Berman DS, Gibbons RJ, Johnson LL, Rumberger JA, Schwaiger M, Wackers FJ: Cardiac positron emission tomography: A report for health professionals from the Committee on Advanc‐ed Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation 1991; 84: 447–454 [DOI] [PubMed] [Google Scholar]
- 25. Gould KL: Does positron emission tomography improve patient selection for coronary revascularization? J Am Coll Cardiol 1992; 20: 566–568 [DOI] [PubMed] [Google Scholar]
- 26. Pennell DJ, Underwood ST: Stress magnetic resonance imaging in coronary artery disease In Magnetic Resonance Imaging in Coronary Artery Disease (Eds. van der Wall EE, de Roos A.), p. 217–239. Dordrecht: Kluwer, 1991. [Google Scholar]
- 27. Baer FM, Smolarz K, Jungehulsing M, Bechwilm J, Theissen P, Sechtem U, Schicha H, Hilger HH: Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99m Tc‐methoxyisobutyl‐isonitrile SPECT. Am Heart J 1992; 123: 636–645 [DOI] [PubMed] [Google Scholar]
- 28. Bolster BD, McVeigh ER, Zerhouni EA: Myocardial tagging in polar coordinates with use of striped tags. Radiology 1990; 177: 769–772 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Wilke N, Maching T, Engels G: Dynamic perfusion studies by ultrafast MR imaging: Initial clinical results from cardiology. Electromedica 1990; 58: 102–108 [Google Scholar]
- 30. Manning WH, Atkinson DJ, Grossman W, Paulin S, Edelman RR: First‐pass nuclear magnetic resonance imaging studies using gadolinium‐DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991; 18: 959–965 [DOI] [PubMed] [Google Scholar]
- 31. Schaefer S, van Tyen R, Saloner D: Evaluation of myocardial perfusion abnormalities with gadolinium‐enhanced snapshot MR imaging in humans: Work in progress. Radiology 1992; 185: 795–801 [DOI] [PubMed] [Google Scholar]
- 32. Miller DD, Holmvang G, Gill JB: MRI detection of myocardial perfusion changes by gadolinium‐DTPA infusion during dipyridamole hyperemia. Magn Reson Med 1989; 10: 246–255 [DOI] [PubMed] [Google Scholar]
- 33. Manning WJ, Li W, Adelman RR: A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 1993; 828–832 [DOI] [PubMed]
- 34. Porter TR, D'sa A, Turner C, Manisi AJ, Mohanty PK, Pesko L, Vetrovee GW: Simultaneous assessment of coronary flow reserve using intracoronary Doppler and myocardial contrast echocardiography in humans (abstr). J Am Coll Cardiol 1991; 17: 111A [DOI] [PubMed] [Google Scholar]
- 35. Kaul S: Clinical applications of myocardial contrast echocardiography. Am J Cardiol 1992; 69: 46H–55H [DOI] [PubMed] [Google Scholar]
- 36. Limacher MC, Quinones MA, Poliner LR, Nel JG, Winters WL, Waggoner AD: Detection of coronary artery disease with exercise two‐dimensional echocardiography: Description of a clinically applicable method and comparison with radionuclide ventriculography. Circulation 1983; 67: 1211–1218 [DOI] [PubMed] [Google Scholar]
- 37. Kaul S: Review: Assessment of myocardial perfusion with contrast two‐dimensional echocardiography. Am J Med Sci 1990; 299: 113–129 [DOI] [PubMed] [Google Scholar]
- 38. Dittrich HC, Bales GL, McFerran BA, Kuvelas MT, Hunt RM: Reproducibility of myocardial opacification using FS069, a new intravenously administered ultrasound contrast agent (abstr). J Am Coll Cardiol 1995;February: 204A
- 39. Xu J, Pantely GA, Ge S, Grauer S, Shiota T, Gong Z, Zhou X: Contrast echocardiography assessment of myocardial perfusion following acute coronary artery occlusion and reperfusion using intravenous injection of Aerosome MRX 115 in monkeys (abstr). J Am Coll Cardiol 1995;February: 204A
- 40. Cotter B, Kwan OL, Lesse P, DeMaria AN: Safety and efficacy of QW3600 (EchoGen) in producing LB opacification during stress echocardiography in normals (abstr). J Am Coll Cardiol 1995;February: 159A
- 41. Kemper AJ, O'Boyle JE, Cohen CA, Taylor A, Parisi AF: Hydrogen peroxide contrast echocardiography: Quantitation in vivo of myocardial risk area following coronary occlusion and the necrotic area remaining after myocardial reperfusion. Circulation 1984; 70: 309–317 [DOI] [PubMed] [Google Scholar]